CANADA LIFE ASSURANCE Co Has $31.29 Million Stake in Humana Inc. (NYSE:HUM)

CANADA LIFE ASSURANCE Co trimmed its position in Humana Inc. (NYSE:HUM - Free Report) by 4.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 123,469 shares of the insurance provider's stock after selling 6,417 shares during the quarter. CANADA LIFE ASSURANCE Co owned approximately 0.10% of Humana worth $31,288,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of HUM. Vanguard Group Inc. boosted its stake in shares of Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after acquiring an additional 1,751,857 shares during the period. Dodge & Cox increased its holdings in shares of Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares during the last quarter. Pzena Investment Management LLC increased its holdings in shares of Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Humana by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after purchasing an additional 63,562 shares during the period. Finally, Invesco Ltd. lifted its stake in shares of Humana by 29.8% during the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after buying an additional 550,692 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on HUM. Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price target on the stock. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Truist Financial lifted their price target on Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a report on Friday, April 11th. Robert W. Baird upped their price objective on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Finally, Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average target price of $284.90.

Humana Price Performance

NYSE HUM traded up $4.76 during trading on Wednesday, hitting $263.68. 1,081,378 shares of the company's stock were exchanged, compared to its average volume of 1,757,180. The stock's 50 day moving average price is $265.74 and its two-hundred day moving average price is $270.19. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $31.82 billion, a PE ratio of 26.50, a P/E/G ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's dividend payout ratio is presently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.